PATENTS:
Issued
Weber GF (inventor). Peptide sequence that promotes tumor invasion. US Patents 7,807,790 B2 (2010) and 8,969,020 (2015).
Weber GF (inventor). Peptide sequence that promotes tumor invasion. European Patent 1 949 109 B1 – Germany, England, France, Sweden (2012).
Mirza M, Shaughnessy E, Weber GF, Hurley JK, Vanpatten KA, Pestano G (inventors). Grading, staging and prognosing cancer using osteopontin-c. European Patent WO2009052286A1 – Switzerland, Germany, Denmark, Spain, France, Great Britain, Italy (2015).
Mirza M, Shaughnessy E, Weber GF, Hurley JK, Vanpatten KA, Pestano G (inventors). Grading, staging and prognosing cancer using osteopontin-c. US Patents 9,873,915 (2018) and 10,934,591 B2 (2021). Roche press release: http://www.4-traders.com/amp/ROCHE-HOLDING-LTD-9364975/news/Roche-U-S-Patents-Awarded-to-Inventors-in-Arizona-Jan-27-25884638/
Pending
Weber GF (inventor). A prognostic test for early-stage breast lesions. US Patent Application 62/554,712 and PCT Application WO/2019/051041 (filed 09/2018).
Weber GF (inventor). Isolated antibodies and fragments thereof with specificity for Osteopontin-c. International Patent Application PCT/US2021/035379 (filed 06/2021).